{"nctId":"NCT00565747","briefTitle":"Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF","startDateStruct":{"date":"2007-11"},"conditions":["Infertility"],"count":1332,"armGroups":[{"label":"Test culture","type":"EXPERIMENTAL","interventionNames":["Device: Test culture"]},{"label":"Control culture","type":"PLACEBO_COMPARATOR","interventionNames":["Device: Control culture"]}],"interventions":[{"name":"Test culture","otherNames":["EmbryoGen"]},{"name":"Control culture","otherNames":["EmbryoAssist"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* The couple or single woman has signed an informed consent form before any trial-related activities.\n* In Vitro Fertilization (IVF) or IntraCytoplasmic Sperm Injection (ICSI) treatment indicated\n* 25-39 years of age (both inclusive)\n* Regular menstrual cycle: 21-35 days (both inclusive)\n* Women treated with a standard Gonadotropin-Releasing Hormone (GnRH) agonist or antagonist protocol and a Follicle Stimulating Hormone (FSH) / human Menopausal Gonadotropin (hMG) starting dose between 100 and 300 IU daily.\n* human Chorionic Gonadotropin (hCG) administration when the leading follicle has a calculated diameter of minimum 17 mm, or the day after.\n* At least 3 follicles with a calculated diameter of ≥ 14 mm at the day of hCG.\n\nExclusion Criteria:\n\n* The woman has previously participated in the DK001 study.\n* Use of assisted hatching.\n* Indication for Testicular Sperm Aspiration (TESA) or Percutaneous Epididymal Sperm Aspiration (PESA)\n* Any medical conditions or genetic disorders prohibiting IVF/ICSI or interfering with the interpretation of results of the study (including pre-implantation genetic diagnostics).\n* Use of any investigational drug within 30 days before oocyte retrieval\n* Any severe chronic disease of relevance for reproductive function.\n* Oocyte donation patients (donor or recipient).","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"25 Years","maximumAge":"39 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ongoing Implantation Rate Week 7","description":"Defined as number of gestational sacs with fetal heart beat, shown by ultrasound in gestational week 7 in percentage of number of embryo transferred.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.5","spread":null},{"groupId":"OG001","value":"20.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Top Quality Embryos (TQE´s)","description":"Number of 4-5 cell embryo at 44 hours,at least 7 cell embryo at 68 hours, maximum 20% fragmentation, equally large blastomeres (less than 25% difference in size),No signs of multinucleation. Calculated in percentage of number of 2 pronuclei (2PN) oocytes.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.6","spread":null},{"groupId":"OG001","value":"16.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Live Birth","description":"Subject having at least one live birth. Including a foetus which breathes or shows any other evidence of life after expulsion/extraction from its mother. The definition is independent of the duration of the pregnancy (ICMART/WHO criteria).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.9","spread":null},{"groupId":"OG001","value":"24.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":13,"n":654},"commonTop":["Miscarriage"]}}}